Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital

Authors: Jan W. T. Deelen, Caroline E. Visser, Jan M. Prins, Reinier M. van Hest

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

The prophylactic use of antimicrobial agents to prevent infections in non-surgical situations has hardly been investigated. We investigate the extent, indications and appropriateness of antimicrobial prophylaxis given outside the operating room in a tertiary care hospital.

Methods

Four point-prevalence surveys were conducted in which all inpatients on that day were screened for the use of prophylactic antimicrobials: medical prophylaxis, prophylaxis around non-surgical interventions and surgical prophylaxis given on the ward. The primary endpoint was the extent of prophylaxis relative to the total number of antimicrobial prescriptions. We also investigated per prescription the presence of a (local) protocol and adherence to these protocols.

Results

We registered in total 1020 antimicrobial prescriptions, of which 317 (31.1%) were given as prophylaxis. 827/1020 were antibiotic prescriptions. Of these antibiotic prescriptions, 17.0% was medical prophylaxis, 2.7% prophylaxis around non-surgical interventions and 6.9% surgical prophylaxis administered on a ward. For medical antibiotic prophylaxis, a protocol was present in 125 of 141 prescriptions (88.7%); the protocol was followed in 118 cases (94.4%). For prophylaxis around non-surgical interventions and surgical prophylaxis on the wards, protocol presence and adherence rates were 59.1% and 92.3%, and 73.3% and 97.6% respectively. Of the 96 antiviral and 97 antifungal prescriptions, 42.7% and 57.8%, respectively, were medical prophylaxis, of which 95.1 and 96.3% were prescribed according to protocols respectively.

Conclusions

Antimicrobial prophylaxis outside the operating theatre is responsible for a considerable part of total in-hospital antimicrobial use. For most prescriptions there was a protocol and adherence to the protocols was high. The main targets for improvement were prophylaxis around non-surgical interventions and surgical prophylaxis given on the ward.
Literature
1.
go back to reference Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg. 2009;249:551–6.CrossRefPubMed Bowater RJ, Stirling SA, Lilford RJ. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg. 2009;249:551–6.CrossRefPubMed
2.
go back to reference Sutcliffe JA, Briggs JH, Little MW, McCarthy E, Wigham A, Bratby M, et al. Antibiotics in interventional radiology. Clin Radiol. 2015;70:223–34.CrossRefPubMed Sutcliffe JA, Briggs JH, Little MW, McCarthy E, Wigham A, Bratby M, et al. Antibiotics in interventional radiology. Clin Radiol. 2015;70:223–34.CrossRefPubMed
3.
go back to reference Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52:e56–93.CrossRefPubMed Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2011;52:e56–93.CrossRefPubMed
4.
go back to reference Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81:81–9.CrossRefPubMed Khashab MA, Chithadi KV, Acosta RD, Bruining DH, Chandrasekhara V, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81:81–9.CrossRefPubMed
6.
go back to reference Usluer G, Ozgunes I, Leblebicioglu H, Turkish Antibiotic Utilization Study G. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.CrossRefPubMedPubMedCentral Usluer G, Ozgunes I, Leblebicioglu H, Turkish Antibiotic Utilization Study G. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.CrossRefPubMedPubMedCentral
7.
go back to reference Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents. 2007;29:693–9.CrossRefPubMed Seaton RA, Nathwani D, Burton P, McLaughlin C, MacKenzie AR, Dundas S, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents. 2007;29:693–9.CrossRefPubMed
8.
go back to reference Lee C, Walker SA, Daneman N, Elligsen M, Palmay L, Coburn B, et al. Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital. J Epidemiol Glob Heal. 2015;5:143–50.CrossRef Lee C, Walker SA, Daneman N, Elligsen M, Palmay L, Coburn B, et al. Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital. J Epidemiol Glob Heal. 2015;5:143–50.CrossRef
9.
go back to reference Akhloufi H, Streefkerk RH, Melles DC, de Steenwinkel JE, Schurink CA, Verkooijen RP, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34:1631–7.CrossRefPubMedPubMedCentral Akhloufi H, Streefkerk RH, Melles DC, de Steenwinkel JE, Schurink CA, Verkooijen RP, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34:1631–7.CrossRefPubMedPubMedCentral
10.
go back to reference van Spreuwel PC, Blok H, Langelaar MF, Kullberg BJ, Mouton JW, Natsch S. Identifying targets for quality improvement in hospital antibiotic prescribing. Neth J Med. 2015;73:161–8.PubMed van Spreuwel PC, Blok H, Langelaar MF, Kullberg BJ, Mouton JW, Natsch S. Identifying targets for quality improvement in hospital antibiotic prescribing. Neth J Med. 2015;73:161–8.PubMed
13.
go back to reference Robert J, Péan Y, Varon E, Bru J-P, Bedos J-P, Bertrand X, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. Oxford University Press2012;67:1020–6.CrossRefPubMed Robert J, Péan Y, Varon E, Bru J-P, Bedos J-P, Bertrand X, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. Oxford University Press2012;67:1020–6.CrossRefPubMed
14.
go back to reference van den Bosch CM, Geerlings SE, Natsch S, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60:281–91.CrossRefPubMed van den Bosch CM, Geerlings SE, Natsch S, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2015;60:281–91.CrossRefPubMed
15.
go back to reference Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008;54:1270–86.CrossRefPubMed Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008;54:1270–86.CrossRefPubMed
17.
go back to reference Gradl G, Horn C, Postl LKL, Miethke T, Gollwitzer H. Antibiotic prophylaxis in primary and revision hip arthroplasty: what is the evidence? Orthopade. 2011;40:520–7.CrossRefPubMed Gradl G, Horn C, Postl LKL, Miethke T, Gollwitzer H. Antibiotic prophylaxis in primary and revision hip arthroplasty: what is the evidence? Orthopade. 2011;40:520–7.CrossRefPubMed
18.
go back to reference Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. In: Stern A, editor. Cochrane Database Syst. Rev. Chichester: Wiley; 2014. Stern A, Green H, Paul M, Vidal L, Leibovici L. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. In: Stern A, editor. Cochrane Database Syst. Rev. Chichester: Wiley; 2014.
Metadata
Title
Antimicrobial prophylaxis outside the operating theatre, an audit in a university hospital
Authors
Jan W. T. Deelen
Caroline E. Visser
Jan M. Prins
Reinier M. van Hest
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2354-4

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue